DDIT4 and sarcopenia: Collectively, these findings underscore that FoxO signaling does not act in isolation but rather serves as a molecular hub, integrating multiple upstream regulators (e.g., DDIT4) and intersecting with inflammatory pathways (e.g., STAT3), thereby contributing to the shared pathogenesis of osteoporosis and sarcopenia.